Application Nr Approved Date Route Status External Links
NDA022145 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Isentress® Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus (Hiv-1) Infection In Patients 4 Weeks Of Age And Older. The Use Of Other Active Agents With Isentress Is Associated With A Greater Likelihood Of Treatment Response [See Clinical Studies (14) ] . Isentress Is A Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor (Hiv-1 Insti) Indicated: In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Patients 4 Weeks Of Age And Older ( 1 ). The Use Of Other Active Agents With Isentress Is Associated With A Greater Likelihood Of Treatment Response ( 14 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Raltegravir Potassium RALTEGRAVIR POTASSIUM ZINC13831130

Comments